The last few years have emphasized the need for high-quality healthcare for patients that is accessible and affordable for all.
Share: email Subscribe
Weekly Top Stories Tue, 22 Aug 2023
We have 30 articles this week, #Novartis plans Sandoz spin-off around Oct. 4, proposes share. #Experity Acquires Teleradiology PACS Platform OnePACS. #Doccla Acquires OpenTeleHealth, Expanding in 12 Markets. #Bruker Corporation and PhenomeX Inc. Announce a Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction. #MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares.
Editor's Choice
1. 
Improving Healthcare Outcomes with a Strong Payer-Provider Relationship
2. 
Unite Us Launches New, Secure Chat Feature
3. 
Why Maternity Care Deserts Aren’t Going Away. Here’s What can be Done
4. 
Nebraska Medicine and Helix Launch Genomic Testing Statewide
5. 
Transforming Healthcare & Life Sciences with 5G Connectivity
Top 10 M&A Transactions
6. 
Novartis Plans Sandoz Spin-off Around Oct. 4, Proposes Share.
7. 
Experity Acquires Teleradiology PACS Platform OnePACS
8. 
Doccla Acquires OpenTeleHealth, Expanding in 12 Markets
9. 
Bruker Corporation and PhenomeX Inc. Announce a Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction.
10. 
MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
11. 
Orbita Acquires Wellbe Assets, Creating Seamless Digital Pathway
12. 
Frontage Acquires Nucro-Technics Inc. and Nucro-Technics Holdings, Inc.
13. 
Eyenovia Acquires U.S. Commercial Rights to APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension, 0.05%) from Formosa Pharmaceuticals
14. 
Sanofi Bid First, But Biogen Won Out in Fight to Acquire Reata
15. 
RVL Pharmaceuticals (NASDAQ: RVLP) Enters Agreements for $5M Registered Direct Offering
Top 4 Venture Funding
16. 
Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
17. 
Alterity Therapeutics Receives A$4.74M Research & Development Tax Incentive Refund
18. 
mRNA JV Arcalis Awarded $115m from Japanese Gov
19. 
Visana Health Raises $10.1M for Virtual Women’s Health Clinic
Top 4 Partnerships Announcements
20. 
Dolbey, SOAP Health Partner on AI-Driven Early Disease Detection
21. 
CareFirst BlueCross BlueShield, Ryse Health Partner to Accelerate VBC for Diabetes Patients
22. 
Satio Partners with BARDA DRIVe to Develop a Novel Patch-Based Ebolavirus Diagnostic
23. 
AliveCor and Clario Partner to Offer Decentralized Clinical Trials- Focused Six-Lead ECG Solutions
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us